Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transient Receptor Potential Vanilloid Subtype 1 (TRPV1) is a nonselective cation channel that functions as a polymodal sensor, activated by capsaicin, noxious heat, protons, and endogenous lipids. It plays a key role in peripheral nociception, thermoregulation, and inflammation, making it a therapeutic target for various pain and inflammatory conditions.
TRPV1 is a nonselective cation channel that opens in response to various stimuli (capsaicin, heat, protons, lipids), allowing influx of cations (Ca2+, Mg2+, Na+, K+, Cs+) and subsequent neuronal depolarization and signaling.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient Receptor Potential Vanilloid Subtype 1 (TRPV1).